Close

News Releases

News Releases

Aug 06, 2021
CINCINNATI , Aug. 06, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ) today announced financial results for the third quarter ended June 30, 2021 . Third Quarter 2021 Highlights (Comparison to Third Quarter Fiscal 2020): • Consolidated net revenues of $63.5 million , down 25%
Aug 02, 2021
CINCINNATI , Aug. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. , a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it closed the previously announced acquisition of the North American BreathTek ® business from Otsuka America